After five years the ADVANCE project has managed to deliver a Blueprint document based on the project outputs, summarising methods, infrastructure, scenarios and sustainability for conducting different types of studies related to post-marketing vaccine coverage, benefit and risk monitoring.
The ADVANCE Blueprint, written by ECDC, has undergone a broad stakeholder and public consultation.
The Blueprint is a framework on how to use the ADVANCE systems for monitoring vaccine coverage, benefits and risks in Europe; created by the ECDC, that has undergone public consultation.
The Blueprint allows you to rapidly provide scientific evidence on post-marketing vaccination benefits and risks for informed decisions.
|The ADVANCE Blueprint|